WO2016012878A1 - Pre-filled injection device - Google Patents
Pre-filled injection device Download PDFInfo
- Publication number
- WO2016012878A1 WO2016012878A1 PCT/IB2015/054569 IB2015054569W WO2016012878A1 WO 2016012878 A1 WO2016012878 A1 WO 2016012878A1 IB 2015054569 W IB2015054569 W IB 2015054569W WO 2016012878 A1 WO2016012878 A1 WO 2016012878A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- injection device
- reservoir
- fraction
- filled injection
- solution
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/28—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
- A61M5/284—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle comprising means for injection of two or more media, e.g. by mixing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31596—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms comprising means for injection of two or more media, e.g. by mixing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
- A61M5/31576—Constructional features or modes of drive mechanisms for piston rods
- A61M5/31578—Constructional features or modes of drive mechanisms for piston rods based on axial translation, i.e. components directly operatively associated and axially moved with plunger rod
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
- A61M5/204—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically connected to external reservoirs for multiple refilling
Definitions
- the present description refers to the technical field of syringes or injection cartridges and particularly concerns a pre-filled injection device.
- Said pre-filled syringes or cartridges for example the double chamber ones, are known for a long time and nowadays they are used widely.
- Said double chamber syringes or cartridges include a tubular containment body and two substances, at least one of which is a liquid substance, contained in two initially separated containment chambers, which are defined inside the tubular body.
- the two substances which are for example a solid substance in a powder form and a liquid substance, are intended to be mixed just before being administered/injected to the patient.
- the liquid substance is for example an injectable solvent.
- the two containment chambers are brought in communication in order to reconstruct an injectable solution, for example by providing for a bypass element between the two chambers in the pre-filled syringe or cartridge.
- a general object of the present description is to make a pre-filled injection device available, which allows fulfilling said need.
- FIG. 1 shows a lateral view of a first embodiment of a pre-filled injection device wherein said device is shown in a first operating configuration
- FIG. 2 shows a lateral view of some detached parts of the injection device of figure 1
- - Figure 3 shows a lateral view of the injection device of figure 1 wherein said device is shown in a second operating configuration
- FIG. 4 shows a lateral view of the injection device of figure 1 wherein said device is shown in a third operating configuration
- FIG. 5 shows a lateral view of the injection device of figure 1 wherein said device is shown in a fourth operating configuration
- FIG. 6 shows a lateral view of the injection device of figure 1 wherein said device is shown in a fifth operating configuration
- FIG. 7 shows a lateral view of a second embodiment of a pre-filled injection device wherein said device is shown in a first operating configuration
- FIG. 8 shows a lateral view of the injection device of figure 7 wherein said device is shown in a second operating configuration
- FIG. 9 shows a perspective view of a component of the injection device of figure 7;
- - Figure 11 shows a cross-section view of a further component of the injection device of figure 7;
- FIG. 12 shows a lateral view of the injection device of figure 7 wherein said device is shown in a third operating configuration
- FIG. 13 shows a lateral view of the injection device of figure 7 wherein said device is shown in a fourth operating configuration
- FIG. 14 shows a lateral view of the injection device of figure 7 wherein said device is shown in a fifth operating configuration
- FIG. 15 shows a lateral view of the injection device of figure 7 wherein said device is shown in a sixth operating configuration
- FIG. 16 shows a lateral view of the injection device of figure 7 wherein said device is shown in a seventh operating configuration
- FIG. 17 shows a lateral view of the injection device of figure 7 wherein said device is shown in a eightieth operating configuration.
- a pre-filled injection device 1 which is, in the particular example being depicted, a pre-filled double chamber syringe.
- the pre-filled injection device 1 is a pre- filled cartridge.
- the pre-filled injection device 1 allows the reconst itut ion of an injectable solution and injecting a very small dose of said solution, for example, injecting a solution quantity less than 1 milliliter and preferably equal, or almost equal, to 0.1 milliliters.
- said dose is less than about 1/25 of the injectable solution being reconstituted inside the pre-filled injection device 1 and preferably equal to 1/50 of the reconstituted injectable solution.
- the pre-filled injection device 1 includes a tubular containment body 3, extending between a first opening 4, or front opening, and a second opening 5, or back opening 5.
- a first 8 and a second 9 containment chamber which are hermetically separated from one another.
- the first containment chamber 8 will be named front chamber while the second containment chamber 9 will be named back chamber.
- the pre-filled injection device 1 includes a closure device 2 fastened to the tubular body 3, for example fastened to the external lateral walls of the tubular body 3 at one end portion of the first containment chamber 8.
- the closure device 2 is integral to the tubular body 3 and thus it is an end portion of the tubular body 3.
- the pre-filled injection device 1 includes an ergonomic grip section 12 on the opposite side with respect to the closure device 2, which section is fastened to the tubular body 3 or is integral to the tubular body 3.
- the tubular body 3 is for example in the form of a containment body of a syringe or a cartridge being suitable to contain injectable substances and it is preferably made of glass or plastic material that is transparent or substantially transparent. Preferably, the tubular body 3 is made as a single piece.
- the pre-filled injection device 1 includes:
- first 6 and a second 7 plugs arranged inside the tubular body 3, so as to define therebetween in the tubular body 3 the second containment chamber 9, and adapted to slide inside the tubular body 3 (for example, due to a pushing or pulling force) ;
- the first substance is a highly active substance.
- the first substance is for example a powder, a granulated substance, a sterile tablet or a pressed powder.
- Said first substance can be or can contain an API.
- the first substance includes two different substances for example in the form of two different tablets, each including one of said two different substances.
- the first substance in a case where the first substance is solid, this can be a crystallized or lyophilized substance.
- the version where the first substance is crystallized and not lyophilized is currently the preferred one.
- the first substance in a case where the first substance is a lyophilized powder, it is preferred that said powder is obtained by means of a lyophilization process being carried out before inserting the first substance into the first containment chamber 8.
- Said first substance is for example a highly active substance, such as a beta-lactam antibiotic, or a cephalosporin antibiotic or a cytotoxic antitumor or a hormone or a biological preparation.
- Said first substance can be also a normal active ingredient, namely an ingredient that cannot be defined as being highly active.
- Plugs 6, 7 are made of plastic material, for example, they hermetically engage to the internal walls of the tubular body 3 and they can slide inside the tubular body 3 under the action of an external pushing or pulling force.
- said second liquid substance is an injectable solvent, for example a solvent WFI (Water For Injection) or a lidocaine solution or a water and benzyl alcohol solution or a sodium chloride physiological solution or in general any injectable substance adapted to reconstruct another solid or liquid substance.
- the second liquid substance can be or can include an API
- the first plug 6, also named intermediate plug 6, includes at least one bypass channel being initially in a closed state and being adapted to be led to an open state following the application of an external force, for example a pushing force on the plug.
- Plugs having bypass channels are generally known to those skilled in the art in the sector of pre-filled injection devices and therefore they will not be further described.
- the containment body 3 includes an internal wall provided with a recess 10 being adapted to define a bypass channel. In the initial configuration depicted in figure 1, that recess is arranged between the first plug 6 and the first opening 4.
- the second plug 7, or back plug 7 includes a fastening element adapted to fasten a plunger 52 to the second plug 7 so that the second plug 7 can slide inside the tubular body 3 under the pushing or pulling action of plunger 52.
- Said fastening element includes for example an internally threaded blind hole made in the thickness of the second plug 7, inside which a complementary threaded end portion of plunger 52 can be inserted and screwed.
- the first plug 6 is separated from the first opening 4 in order to delimit the first containment chamber 8, or front chamber 8, between the first plug 6 and the first opening 4.
- the pre-filled injection device 1 also includes a dosing reservoir 20, having an inlet opening 21 and an outlet opening 22.
- the inlet opening 21 is in communication with the first containment chamber 8 so that the first containment chamber 8 extends between the first plug 6 and the inlet opening 21 of the dosing reservoir 20.
- the dosing reservoir 20 is defined inside the closure device
- the dosing reservoir is made of a transparent or translucent material so that it is possible to see its content from outside and preferably, it includes a graduated scale that is also visible from outside.
- the pre- filled injection device 1 includes one needle 24 whose internal channel is in fluid communication with the outlet opening 22 of the dosing reservoir 20.
- the needle 24 is fastened to the dosing reservoir 20 on the opposite side with respect to the first containment chamber 8.
- the pre-filled injection device 1 includes a protective shield 25 for the needle 24.
- the protective shield 25 is a telescopic shield formed by a plurality of axially aligned sections which, starting form an initial configuration being shown, for example, in figure 1, can be led to an open configuration being shown, for example, in figure 5.
- the protective shield 25 has an end portion being sealed by a removable and/or pierceable membrane or sheet 26.
- the first plug 6 closes the inlet opening of the dosing reservoir 20;
- the dosing reservoir 20 is filled with a fraction of the reconstituted solution (from now on being named "third fraction") being the solution dose to be administered to the patient.
- the dosing reservoir 20 contains a fraction of the reconstituted solution. More precisely, the dosing reservoir 20 isolates said fraction.
- said third fraction is less than 1/25 of the reconstituted injectable solution and preferably equal to 1/50 of the reconstituted injectable solution.
- the volume of said dosing reservoir 20 is about one milliliter or about one tenth milliliter.
- the first plug 6 includes a projecting appendix 16 adapted to pass through the inlet opening 21 of the dosing reservoir 20 and to enter the latter in order to eject the third fraction of solution from the dosing reservoir 20. That happens for and during the administering of the third fraction of solution.
- said projecting appendix 16 has a right cylinder shape more preferably having a circular cross- section .
- said projecting appendix 16 has a cross-section area equal to or slightly less than that of the inlet opening of the dosing reservoir 20 so that it can enter the dosing reservoir 20 hermetically engaging with the internal walls of the dosing reservoir 20 during its sliding movement inside the latter.
- the pre-filled injection device 1 includes an opening 23, or a vent channel 23, (from now generally named "vent path") adapted to be passed through by the second solution fraction for the ejection of the second fraction and to allow the projecting appendix 16 to pass through the inlet opening 21 of the dosing reservoir 20.
- vent path 23 is provided for in the closure device 2.
- said vent path 23 is a path initially closed by, for example :
- Said vent path 23 is configured to be opened preferably starting from configuration of figure 5 in order to allow the pre-filled injection device 1 passing to configuration of figure 6.
- the injection device 1 includes a cannula 26 for ejecting the second solution fraction or an outer collection reservoir of the second solution fraction, and wherein said outlet section is connected or connectable to the cannula 26 or the outer collection reservoir.
- the second fraction is intended to be ejected through the vent path 23 at the same time the third fraction of reconstituted solution is ejected from the dosing reservoir 20, for administering it.
- At least one storing reservoir 32, 26 is provided for in the injection device 1, adapted to pass from a closed configuration to an open one following a pressing force being exerted by the first plug 6 against the second fraction of reconstituted solution in order to be filled by the second fraction of reconstituted solution and to allow the projecting appendix 16 passing through the inlet opening of the dosing reservoir 20 and enter into the dosing reservoir 20.
- the total capacity of the storing reservoir 32, 36 is equal to the capacity of the dosing reservoir 20.
- the storing reservoir 32, 36 is an annular reservoir.
- the storing reservoir 32, 36 is initially occluded by a tearable membrane or film 42, 46, and therefore it cannot initially receive the reconstituted solution.
- the storing reservoir comprises two reservoir portions 42 and 46 respectively defined in the closure device 2 and the first plug 6.
- Each of such storing reservoir portions 42, 46 has an annular and/or semi-toroidal shape, and it is initially closed by a corresponding tearable membrane or film 42, 46.
- said two reservoir portions 42, 46 face each other and initially, that is in the operating configuration of figure 7, they are on opposite ends of the first containment chamber 8.
- FIG 7 also in this case initially in the operating configuration being depicted in that figure, named initial configuration, a first 8 and a second 9 containment chamber being hermetically separated from each other are defined inside the tubular body 3. In that configuration, the two reservoir portions 42, 46 are sealed.
- the first plug 6 closes the inlet opening 21 of the dosing reservoir 20;
- the dosing reservoir 20 is filled with a third fraction of the injectable solution being a dose to be administered to the patient.
- the second fraction of liquid being incompressible, causes a break or a tear in the tearable films or membranes 42, 46 and causes the second fraction to enter into the storing reservoir 32, 36 as depicted in figure 14 (end of administering configuration) .
- the two storing reservoir portions 32, 36 are facing each other in order to define a single toroidal reservoir, which, in the depicted particular example, surrounds the projecting appendix 16 of the first plug 6.
- the tearable films or membranes 42, 46 break or tear, the projecting appendix 16 enters into the storing reservoir 20 and the reconstituted solution contained therein is administered through the needle 24.
- the two plugs 6, 7 are provided with fastening elements, for example engaging elements, which allow the two plugs 6, 7 to be fastened together, once the second plug 7 contacts the first plug 6 and a further pushing force is applied to plunger 52 (in the figures, that happens passing form configuration of figure 8 to configuration of figure 12) .
- said fastening elements include a bulb appendix 71 protruding from the second plug 7 towards the first plug 6 and an opposing conjugated recess 61 being defined inside the first plug 6.
- the forced entry of the bulb appendix 71 inside the conjugated recess 61 causes the two plugs 6, 7 to couple, making them integral to each other.
- the second fraction is intended to enter the storing reservoir 32, 36 at the same time the third fraction of reconstituted solution is ejected from the dosing reservoir 20, for administering it.
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Description
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2952845A CA2952845C (en) | 2014-07-22 | 2015-06-17 | Pre-filled injection device |
CN201580039578.0A CN106535964B (en) | 2014-07-22 | 2015-06-17 | pre-filled injection device |
JP2017502869A JP6689816B2 (en) | 2014-07-22 | 2015-06-17 | Prefilled syringe |
LTEP15741330.3T LT3171918T (en) | 2014-07-22 | 2015-06-17 | Pre-filled injection device |
ES15741330.3T ES2675890T3 (en) | 2014-07-22 | 2015-06-17 | Preloaded injection device |
US15/326,969 US10363375B2 (en) | 2014-07-22 | 2015-06-17 | Pre-filled injection device |
PL15741330T PL3171918T3 (en) | 2014-07-22 | 2015-06-17 | Pre-filled injection device |
EP15741330.3A EP3171918B1 (en) | 2014-07-22 | 2015-06-17 | Pre-filled injection device |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM2014A000408 | 2014-07-22 | ||
ITRM20140408 | 2014-07-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2016012878A1 true WO2016012878A1 (en) | 2016-01-28 |
Family
ID=51663329
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2015/054569 WO2016012878A1 (en) | 2014-07-22 | 2015-06-17 | Pre-filled injection device |
Country Status (11)
Country | Link |
---|---|
US (1) | US10363375B2 (en) |
EP (1) | EP3171918B1 (en) |
JP (1) | JP6689816B2 (en) |
CN (1) | CN106535964B (en) |
CA (1) | CA2952845C (en) |
ES (1) | ES2675890T3 (en) |
LT (1) | LT3171918T (en) |
PL (1) | PL3171918T3 (en) |
PT (1) | PT3171918T (en) |
TR (1) | TR201809101T4 (en) |
WO (1) | WO2016012878A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITUA20162549A1 (en) * | 2016-04-13 | 2017-10-13 | Orofino Pharmaceuticals Group Srl | INJECTION DEVICE WITH STORAGE TANK FOR A FRACTION OF SOLUTION |
ITUA20164317A1 (en) * | 2016-06-13 | 2017-12-13 | Orofino Pharmaceuticals Group Srl | INJECTION DEVICE PRE-FILLED WITH A TRIPLE ROOM |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9937317B2 (en) * | 2012-01-30 | 2018-04-10 | Ipsumpro, S.L. | Modified medical syringe with a flow regulator for the administration of local anaesthetic |
JP2018531065A (en) * | 2015-10-02 | 2018-10-25 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | Multi-chamber syringe unit and method for making multi-chamber syringe |
CN107089441B (en) * | 2017-06-13 | 2020-06-02 | 苏州中科生物医用材料有限公司 | Cartilage repair instrument |
IT201800009185A1 (en) * | 2018-10-05 | 2020-04-05 | Orofino Pharmaceuticals Group Srl | Syringe for the reconstitution and injection of a pharmaceutical solution |
TWI731660B (en) * | 2020-04-24 | 2021-06-21 | 透策生技股份有限公司 | Processing method for accelerating the dispersion of injection-type fillers by means of pressurization |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0815886A2 (en) * | 1996-06-28 | 1998-01-07 | Becton, Dickinson and Company | A stopper assembly having bypass for use in a multi-chamber syringe barrel |
WO2006003653A2 (en) * | 2004-07-04 | 2006-01-12 | M.L.I.S. Projects Limited | A syringe assembly |
US20140128817A1 (en) * | 2009-06-02 | 2014-05-08 | Sanofi-Aventis Deutschland Gmbh | Medicated Module with User Selection |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3172005B2 (en) * | 1992-11-27 | 2001-06-04 | 株式会社大協精工 | Syringe and container |
US5713857A (en) * | 1996-06-28 | 1998-02-03 | Becton Dickinson France, S.A. | Sequential stopper |
DE10129585A1 (en) * | 2001-06-20 | 2003-01-09 | Disetronic Licensing Ag | Device for the dosed administration of an injectable product |
SE526878C2 (en) * | 2003-06-18 | 2005-11-15 | Q Med Ab | Medical pump |
JP4164771B2 (en) * | 2006-07-10 | 2008-10-15 | 日本電気株式会社 | Load balance type switch device and load balance type switch method |
JP5677846B2 (en) * | 2007-09-27 | 2015-02-25 | ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company | Cartridge for powder and liquid drugs |
CN102458521B (en) * | 2009-06-04 | 2014-06-04 | 诺沃—诺迪斯克保健股份有限公司 | Mixing device with piston coupling arrangement |
US20120013629A1 (en) * | 2010-07-19 | 2012-01-19 | Advanced Micro Devices, Inc. | Reading Compressed Anti-Aliased Images |
CN103285454A (en) * | 2012-02-29 | 2013-09-11 | 山东威高集团医用高分子制品股份有限公司 | Double-chamber multifunctional pre-encapsulation injector |
JP5870018B2 (en) * | 2012-12-17 | 2016-02-24 | 株式会社大塚製薬工場 | Pre-filled syringe chemical recovery tool and pre-filled syringe with chemical recovery function |
-
2015
- 2015-06-17 ES ES15741330.3T patent/ES2675890T3/en active Active
- 2015-06-17 CN CN201580039578.0A patent/CN106535964B/en active Active
- 2015-06-17 CA CA2952845A patent/CA2952845C/en active Active
- 2015-06-17 PL PL15741330T patent/PL3171918T3/en unknown
- 2015-06-17 LT LTEP15741330.3T patent/LT3171918T/en unknown
- 2015-06-17 WO PCT/IB2015/054569 patent/WO2016012878A1/en active Application Filing
- 2015-06-17 PT PT157413303T patent/PT3171918T/en unknown
- 2015-06-17 US US15/326,969 patent/US10363375B2/en active Active
- 2015-06-17 EP EP15741330.3A patent/EP3171918B1/en active Active
- 2015-06-17 TR TR2018/09101T patent/TR201809101T4/en unknown
- 2015-06-17 JP JP2017502869A patent/JP6689816B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0815886A2 (en) * | 1996-06-28 | 1998-01-07 | Becton, Dickinson and Company | A stopper assembly having bypass for use in a multi-chamber syringe barrel |
WO2006003653A2 (en) * | 2004-07-04 | 2006-01-12 | M.L.I.S. Projects Limited | A syringe assembly |
US20140128817A1 (en) * | 2009-06-02 | 2014-05-08 | Sanofi-Aventis Deutschland Gmbh | Medicated Module with User Selection |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITUA20162549A1 (en) * | 2016-04-13 | 2017-10-13 | Orofino Pharmaceuticals Group Srl | INJECTION DEVICE WITH STORAGE TANK FOR A FRACTION OF SOLUTION |
WO2017178962A1 (en) * | 2016-04-13 | 2017-10-19 | Orofino Pharmaceuticals Group Srl | Injection device with dosing reservoir for a fraction of solution |
CN109195648A (en) * | 2016-04-13 | 2019-01-11 | 奥罗菲诺制药集团责任有限公司 | Injection device with the dosage reservoir for a part of solution |
JP2019511319A (en) * | 2016-04-13 | 2019-04-25 | オロフィーノ ファーマシューティカルズ グループ エスアールエル | Syringe with dispensing reservoir for part of solution |
US20190125974A1 (en) * | 2016-04-13 | 2019-05-02 | Orofino Pharmaceuticals Group Srl | Injection device with dosing reservoir for a fraction of solution |
ITUA20164317A1 (en) * | 2016-06-13 | 2017-12-13 | Orofino Pharmaceuticals Group Srl | INJECTION DEVICE PRE-FILLED WITH A TRIPLE ROOM |
WO2017216651A1 (en) * | 2016-06-13 | 2017-12-21 | Orofino Pharmaceuticals Group Srl | Triple chamber with prefilled injection device |
CN109310830A (en) * | 2016-06-13 | 2019-02-05 | 奥罗菲诺制药集团责任有限公司 | The prefilled injection devices of three chambers |
JP2019517348A (en) * | 2016-06-13 | 2019-06-24 | オロフィーノ ファーマシューティカルズ グループ エスアールエル | Triple compartment prefilled syringe |
EA035878B1 (en) * | 2016-06-13 | 2020-08-25 | Орофино Фармасьютикалз Груп Срл | Triple chamber prefilled injection device |
Also Published As
Publication number | Publication date |
---|---|
US10363375B2 (en) | 2019-07-30 |
ES2675890T3 (en) | 2018-07-13 |
EP3171918A1 (en) | 2017-05-31 |
CN106535964B (en) | 2019-12-10 |
JP2017522115A (en) | 2017-08-10 |
EP3171918B1 (en) | 2018-04-04 |
PT3171918T (en) | 2018-07-03 |
CA2952845A1 (en) | 2016-01-28 |
JP6689816B2 (en) | 2020-04-28 |
PL3171918T3 (en) | 2018-09-28 |
CN106535964A (en) | 2017-03-22 |
US20170203047A1 (en) | 2017-07-20 |
TR201809101T4 (en) | 2018-07-23 |
CA2952845C (en) | 2023-03-07 |
LT3171918T (en) | 2018-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3171918B1 (en) | Pre-filled injection device | |
EP2934636B1 (en) | Dual chamber mixing syringes and methods of using same | |
JPS6258745B2 (en) | ||
KR20000076536A (en) | Method and system for administering a medication | |
US4543094A (en) | Syringe and accessory | |
US2449968A (en) | Hypodermic syringe | |
KR100989872B1 (en) | Two kind pre-filled syringe | |
EP3468646B1 (en) | Triple chamber with prefilled injection device | |
EP3377148B1 (en) | Autoinjector | |
AU2017300984A1 (en) | Pre-filled injection device with cartridge, having multiple chambers | |
KR101992055B1 (en) | Injecting device for liquid medicine by unit connection | |
EP3442622B1 (en) | Injection device with dosing reservoir for a fraction of solution | |
EP3860688B1 (en) | Syringe for reconstituting and injecting a pharmaceutical solution | |
WO2017178963A1 (en) | Injection device with protective cap | |
JP2008104776A (en) | Container-cum-syringe | |
KR20150002026A (en) | Medical solution bag kit having auxiliary chamber of syringe type |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15741330 Country of ref document: EP Kind code of ref document: A1 |
|
REEP | Request for entry into the european phase |
Ref document number: 2015741330 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2015741330 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2952845 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2017502869 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 15326969 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |